We are live on ! Find out more
ZEPP icon

Zepp Health

61 hedge funds and large institutions have $200M invested in Zepp Health in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more call options, than puts

Call options by funds: $85K | Put options by funds: $49K

71% more capital inflows, than outflows

Capital inflows: $31.7M | Capital outflows: $18.6M

2% less funds holding

Funds holding: 62 → 61 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

39% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 28

Holders
61
Holders Change
-1
Holders Change %
-1.61%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
28
Closed
10
Calls
$85K
Puts
$49K
Net Calls
+$36K
Net Calls Change
+$580K

ZEPP Hedge Fund Activity: Q2 2020 in Review

61 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q2 2020, worth a combined $200M — up 3.3% from $193M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ZEPP and 9 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 17 added.

The largest buyer was Franklin Resources, adding an estimated $14M. The largest seller was Goldman Sachs, cutting an estimated $7.26M.

  • 61 institutional investors held Zepp Health (ZEPP) as of Q2 2020, down from 62 in Q1 2020.
  • Funds reported $200M of Zepp Health stock for Q2 2020, up 3.3% quarter-over-quarter.
  • 9 funds opened new Zepp Health positions in Q2 2020 and 10 closed out, a net change of -1 holder.
  • The largest Zepp Health buyer in Q2 2020 was Franklin Resources, an estimated $14M added.
  • The largest Zepp Health seller in Q2 2020 was Goldman Sachs, an estimated $7.26M sold.

Based on aggregated 13F filings for Q2 2020.